Pyrrolopyridine derivatives and their use as CRTH2 antagonists

Details for Australian Patent Application No. 2005254681 (hide)

Owner Novartis AG

Inventors Brown, Lyndon Nigel; Cox, Brian; Turner, Katharine Louise; Bala, Kamlesh; Watson, Simon James; Sandham, David Andrew; Leblanc, Catherine

Agent Davies Collison Cave

Pub. Number AU-B-2005254681

PCT Pub. Number WO2005/123731

Priority 0507693.0 15.04.05 GB; 0413619.8 17.06.04 GB

Filing date 16 June 2005

Wipo publication date 29 December 2005

Acceptance publication date 29 January 2009

International Classifications

A61K 31/437 (2006.01)

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2005/123731 Priority application(s): WO2005/123731

29 January 2009 Application Accepted

  Published as AU-B-2005254681

28 May 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005254685-Modified polypropylene composition

2005254665-Use of 6-(2-tolyl)-triazolopyrimidines as fungicides, novel 6-(2-tolyl)-triazolopyrimidines, method for the production thereof, use thereof for controlling harmful fungi, and agents containing the same